1.45% -0.33

Acadia Pharmaceuticals Inc (ACAD)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt ACAD? Forum Prognose

Finanzdaten der Acadia Pharmaceuticals Inc-Aktie (ACAD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-09-30	2024-06-30	2024-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	8.29% 264.57	244.32	250.40	241.96	205.83
Cost Of Revenue	1.68% 20.73	20.39	18.86	18.23	22.95
Gross Profit	8.89% 243.83	223.93	231.54	223.73	182.88
Operating Expenses	3.33% 211.46	204.63	199.90	193.30	167.67
Benefits Costs and Expenses	3.61% 224.35	216.54	211.59	204.78	184.83
Costs And Expenses	3.18% 232.19	225.03	218.76	211.53	190.62
Operating Income/Loss	67.83% 32.37	19.29	31.64	30.44	15.21
Income/Loss From Continuing Operations Before Tax	44.75% 40.21	27.78	38.81	37.18	21.00
Income Tax Expense/Benefit	54.06% 13.54	8.792	6.041	3.793	4.447
Income/Loss From Continuing Operations After Tax	40.44% 26.67	18.99	32.77	33.39	16.55
Net Income/Loss	40.44% 26.67	18.99	32.77	33.39	16.55
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.61% 167.83	166.81	165.97	165.55	164.80
Diluted Average Shares	0.60% 168.68	167.67	166.18	166.17	166.62
Basic Earnings Per Share	45.45% 0.16	0.11	0.20	0.20	0.10
Diluted Earnings Per Share	45.45% 0.16	0.11	0.20	0.20	0.10
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.30

0.64%

GMAB

$28.71

0.35%

INCY

$101.57

8.65%

BNTX

$103.95

0.04%

ONC

$311.86

0.44%

INSM

$186.23

1.78%